A business in context

AIBT research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001096906-26-001264

  2. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001096906-26-000922

  3. 10-K · Annual report

    Report date 2025-12-31 · 0001096906-26-000555

  4. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001096906-25-001895

  5. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001096906-25-001375

  6. 4 · Ownership change

    Report date 2025-07-25 · 0001096906-25-001193

  7. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001096906-25-000861

  8. 10-K · Annual report

    Report date 2024-12-31 · 0001096906-25-000487

  9. 8-K · Current report

    Report date 2025-01-25 · 0001096906-25-000287 · Items 1.01,9.01

  10. 4 · Ownership change

    Report date 2024-12-13 · 0001096906-24-002274

  11. 4 · Ownership change

    Report date 2024-12-13 · 0001096906-24-002273

  12. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001096906-24-002137

  13. 8-K · Current report

    Report date 2024-07-29 · 0001096906-24-001786 · Items 1.01,5.03,9.01

  14. 10-Q · Quarterly report

    Report date 2024-06-30 · 0001096906-24-001763

  15. 10-Q · Quarterly report

    Report date 2024-03-31 · 0001096906-24-001146

  16. 10-K · Annual report

    Report date 2023-12-31 · 0001096906-24-000907

  17. 8-K · Current report

    Report date 2024-03-21 · 0001096906-24-000650 · Items 4.01,9.01

  18. 8-K · Current report

    Report date 2023-11-28 · 0001096906-23-002316 · Items 1.01,2.01,3.02,7.01,9.01

  19. 10-Q · Quarterly report

    Report date 2023-09-30 · 0001096906-23-002130

  20. 10-K/A · Annual report

    Report date 2022-12-31 · 0001096906-23-002096

  21. 10-Q/A · Quarterly report

    Report date 2022-09-30 · 0001096906-23-002094

  22. 10-Q/A · Quarterly report

    Report date 2022-06-30 · 0001096906-23-002008

  23. 10-Q/A · Quarterly report

    Report date 2022-03-31 · 0001096906-23-002006

  24. 10-K/A · Annual report

    Report date 2021-12-31 · 0001096906-23-002003

  25. 10-Q · Quarterly report

    Report date 2023-06-30 · 0001096906-23-001623

  26. 10-Q · Quarterly report

    Report date 2023-03-31 · 0001096906-23-001409

  27. 8-K · Current report

    Report date 2023-04-25 · 0001096906-23-000961 · Items 4.02

  28. 10-K · Annual report

    Report date 2022-12-31 · 0001096906-23-000683

  29. 8-K · Current report

    Report date 2023-02-16 · 0001096906-23-000428 · Items 1.02,7.01,9.01

  30. 10-Q · Quarterly report

    Report date 2022-09-30 · 0001096906-22-002761

  31. 10-Q · Quarterly report

    Report date 2022-06-30 · 0001096906-22-001838

  32. 10-Q · Quarterly report

    Report date 2022-03-31 · 0001096906-22-001262

  33. 8-K · Current report

    Report date 2022-05-18 · 0001096906-22-001188 · Items 1.01,7.01,9.01

  34. 10-K · Annual report

    Report date 2021-12-31 · 0001096906-22-000867

  35. 8-K · Current report

    Report date 2021-11-17 · 0001096906-22-000130 · Items 1.01,9.01

  36. 4 · Ownership change

    Report date 2020-07-28 · 0001445866-20-001118

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

0 matching transaction rows.

No matching transaction rows in the covered quarter. This does not establish that no insider transactions occurred.

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001763329AIBOTICS, INC.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names
  • Mycotopia Therapies, Inc. · former SEC name · 2021-05-20 to 2024-12-17
  • 20/20 Global, Inc. · former SEC name · 2019-01-31 to 2021-05-19

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$0$0
2019-12-31$0$0
2018-12-31$0$0

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗